PLYMOUTH, Minn., Oct. 29, 2026 /PRNewswire/ -- Minnesota based Laplace Interventional today announced that the first three patients have been enrolled and treated in the randomized cohort of their TRIUMPH pivotal trial. These patients were treated at Ballad Health (Kingsport, TN) and Oklahoma Heart Institute (Tulsa, OK) by structural heart teams headed by Dr. Gaurav Rana, MD, Interventional Cardiologist at Ballad Health and Dr. Kamran Muhammad, MD, Director of Structural Heart Program at Oklahoma Heart Institute respectively.